Myriad Genetics (MYGN) Return on Capital Employed (2011 - 2026)
Myriad Genetics (MYGN) posted quarterly Return on Capital Employed of 69.45% for Q1 2026, down 5507.0% year-over-year from 1.28% in Q1 2025, and down 4.67% quarter-over-quarter from 66.35% in Q4 2025.
Myriad Genetics (MYGN) Return on Capital Employed (2011 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Return on Capital Employed for 16 consecutive years, with 69.45% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 5507.0% year-over-year to 69.45%; the TTM figure through Mar 2026 stood at 69.45% (down 5507.0% YoY), while the FY2025 annual figure was 52.8%, down 3942.0% from the prior year.
- Return on Capital Employed eased to 69.45% in Q1 2026 per MYGN's latest filing, from 66.35% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 12.15% in Q3 2022 and bottomed at 75.81% in Q3 2025.
- Historically, Return on Capital Employed has averaged 30.08% across 5 years, with a median of 16.43% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 3195 bps — and 2025, when it sank 6334 bps.
- Myriad Genetics' Return on Capital Employed stood at 13.16% in 2022, then slumped by 97 bps to 25.95% in 2023, then surged by 47 bps to 13.86% in 2024, then tumbled by 379 bps to 66.35% in 2025, then dropped by 5 bps to 69.45% in 2026.
- Business Quant data shows MYGN's Return on Capital Employed at 69.45% in Q1 2026, 66.35% in Q4 2025, and 75.81% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | -69.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.45% |
| Dec 31, 2025 | -66.35% |
| Sep 30, 2025 | -75.81% |
| Jun 30, 2025 | -65.00% |
| Mar 31, 2025 | -14.38% |
| Dec 31, 2024 | -13.86% |
| Sep 30, 2024 | -12.47% |
| Jun 30, 2024 | -16.43% |
| Mar 31, 2024 | -23.73% |
| Dec 31, 2023 | -25.95% |
| Sep 30, 2023 | -29.01% |
| Jun 30, 2023 | -27.49% |
| Mar 31, 2023 | -16.07% |
| Dec 31, 2022 | -13.16% |
| Sep 30, 2022 | -12.15% |
| Jun 30, 2022 | -14.95% |
| Mar 31, 2022 | -15.10% |
| Dec 31, 2021 | -16.95% |
| Sep 30, 2021 | -20.54% |
| Jun 30, 2021 | -36.83% |